DUBLIN--(BUSINESS WIRE)--The "Infant Phototherapy Device Market: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
The global infant phototherapy device market is expected to grow at a CAGR of 3.7% from 2021 to 2030.
Phototherapy is one of the most effective and easy methods to treat infants suffering from neonatal jaundice. It is commonly used to reduce the bilirubin (the compound that leads to jaundice) levels in infants. According to the estimates of the National Collaborating Centre for Women's and Children's Health (UK), nearly 60% of term and 80% of preterm babies develop jaundice within the first week of their birth.
Neonatal jaundice may also be caused due to other non-physiological causes such as blood group incompatibility, hemolysis, sepsis, bruising, and liver enzyme deficiency. During phototherapy, an infant is kept in a plastic crib, and is exposed to a type of light that is absorbed by the skin. During this process, the bilirubin in the infant's body is converted into a much simpler water-soluble form, which can be easily excreted through stool and urine.
The major factors that drive the growth of the global infant phototherapy device market include rise in prevalence of neonatal jaundice and advantages of phototherapy over other treatment methods. In addition, technological advancements in the field of infant phototherapy drive the market growth. However, side effects of phototherapy treatment restrict the market growth.
The infant phototherapy device market is segmented on the basis of type of light lamp, configuration, end user, and region. According to type of light lamp, the market is segregated into fluorescent lamps, light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes. Depending on configuration, the market is divided into mobile device and fixed device. As per end user, the market is bifurcated into hospitals and neonatal clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
- The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets
- It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on prevailing market opportunities
- Analysis by light source helps understand the various types of light sources used in infant phototherapy devices
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market
Key Market Segments
By Light Source
- Light-emitting diodes (LEDs)
- Quartz halogen lamps
- Gas discharge tubes
- Fluorescent lamps (FL)
By Configuration
- Mobile device
- Fixed device
By End User
- Hospitals
- Neonatal clinics
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Players
- Atom Medical Corporation
- AVI Healthcare Pvt Ltd
- Equalize Health Inc
- General Electric Company
- Ibis Medical Equipment & Systems Pvt Ltd
- Natus Medical Incorporated
- Ningbo David Medical Device Co, LTD
- Novos Medical Devices
- Weyer GmbH
- Zhengzhou Dison Instrument and Meter Co., Ltd
For more information about this report visit https://www.researchandmarkets.com/r/hpt7fy
